EastGate Biotech Corp. received an NPN (Natural Product Number) from the Natural and Non-Prescription Health Products Directorate of Health Canada for its natural product Glucora. The NPN product license number for Glucora is 80057426.

Glucora is a natural based formula in self-emulsifying delivery system that provides support for healthy glucose metabolism. Glucora is an addition to a line of natural products, developed at EastGate Biotech Corp. The products are currently available online at website.

As previously announced, the products will be also available under private label by a distributor in the United States. EastGate Biotech's R&D strategy and product analysis included the identification of biologically active compounds having limited absorption due to low solubility. Low absorption of drugs and poor bioavailability can lead to increased dosages taken by patients with the same treatment result.

Increased bioavailability could encourage patient compliance, lower costs of treatment, reduce side effects and improve quality of life. EastGate Biotech's technology platform provides an effective delivery system with increased bioavailability of incorporated compounds. The Company's approach increases solubility of hydrophobic compounds in a proprietary self-emulsifying vehicle using a safe combination of known and approved excipients.

To date, the Company's sub-micron self-emulsifying delivery platform has been used for improvement of dietary supplements as well as pharmaceutical products. Intraoral Lorazepam Spray for seizure treatment and in intraoral insulin tablet for diabetes are in advanced stages of development.